共 50 条
- [41] TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtypePATHOLOGY RESEARCH AND PRACTICE, 2024, 262Di Nunno, VincenzoGatto, LidiaTosoni, AliciaAprile, MartaGalvani, LindaZappi, AriannaFoschini, Maria PiaAsioli, SofiaTallini, GiovanniDe Biase, DarioMaloberti, ThaisBartolini, StefaniaGiannini, CaterinaFranceschi, Enrico
- [42] TP53 and CDKN2A Mutations Correlate with Survival, Stage, and Grade in MesotheliomaLABORATORY INVESTIGATION, 2024, 104 (03) : S1972 - S1973Zhu, AllenHusain, AliyaHermina, AndrewMueller, JeffreyKwon, Jung Woo
- [43] Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancerANNALS OF ONCOLOGY, 2017, 28Martinez Bueno, A.Molina, M. A.Fielding, A.Bertran-Alamillo, J.Dougherty, B. A.Lai, Z.Hodgson, D.Mayo de las Casas, C.Rowe, P.Gil, M.Spencer, S.Viteri, S.Lobera, J.Rosell, R.Gasco Hernandez, A.
- [44] Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancersONCOTARGET, 2015, 6 (21) : 18641 - 18652Seagle, Brandon-Luke L.Eng, Kevin H.Dandapani, MonicaYeh, Judy Y.Odunsi, KunleShahabi, Shohreh
- [45] Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcomaCOMMUNICATIONS BIOLOGY, 2021, 4 (01)Das, SunetraIdate, RupaRegan, Daniel P.Fowles, Jared S.Lana, Susan E.Thamm, Douglas H.Gustafson, Daniel L.Duval, Dawn L.
- [46] TP53 pathogenic variants with low allele fraction in germline genetic testing.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Wu, YanqingFan, WenzheXue, MiaoTang, YiyangPeisu, SuoYang, BoHuang, TanxiaoZhang, JingLi, Jiaping
- [47] KEAP1 and TP53 Mutations in Lung Cancer: More Is Better. Reply to: "Survival Analysis of TP53 Co-Mutations Should Be Interpreted More Cautiously"JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (03) : E40 - E41Scalera, StefanoMazzotta, MarcoCappuzzo, FedericoCiliberto, GennaroMaugeri-Sacca, Marcello
- [48] Clinicopathological and Genetic Ancestry Impact of TP53 Mutations in Brazilian Lung Adenocarcinoma PatientsJOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1209 - S1210De Oliveira Cavagna, R.Escremim De Paula, F.Noriz Berardinelli, G.Sant'Anna, D.Santana, I.Duval Da Silva, V.Albino Da Silva, E. C.Miziara, J. E.Mourao Dias, J.De Marchi, P.Ferro Leal, L.Vieira Reis, R. M.
- [49] TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation.BLOOD, 2009, 114 (22) : 280 - 280Rossi, DavideSpina, ValeriaDeambrogi, ClaraLucioni, MarcoArcaini, LucaRocque, Gabrielle B.Malik, Jeffrey T.Chang, Julie E.Chigrinova, EkaterinaNomdedeu, Josep F.Forconi, FrancescoMarasca, RobertoBesson, CarolineCanzonieri, VincenzoPaulli, MarcoGattei, ValterBertoni, FrancescoYoung, Ken H.Gaidano, Gianluca
- [50] The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation HotspotsHUMAN MUTATION, 2023, 2023Lazarian, GregoryLeroy, BernardTheves, FlorianeHormi, MyriamLetestu, RemiEclache, VirginieTueur, GiuliaAmeur, AdamBidet, AudreyCornillet-Lefebvre, PascaleDavi, FredericDelabesse, EricEstienne, Marie-HeleneEtancelin, PascalineKosmider, OlivierLaibe, SophyMuller, MarcNadal, NathalieNaguib, DinaPastoret, CedricPoulain, StephanieSujobert, PierreVeronese, LaurenImache, SamiaLefebvre, ValerieCymbalista, FlorenceBaran-Marszak, FannySoussi, Thierry